JP2025507864A - 操作された細胞および使用方法 - Google Patents
操作された細胞および使用方法 Download PDFInfo
- Publication number
- JP2025507864A JP2025507864A JP2024552028A JP2024552028A JP2025507864A JP 2025507864 A JP2025507864 A JP 2025507864A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2025507864 A JP2025507864 A JP 2025507864A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- protein
- promoter region
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/31—Chimeric antigen receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
- A61K40/4211—CD19 or B4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315579P | 2022-03-02 | 2022-03-02 | |
| US202263315581P | 2022-03-02 | 2022-03-02 | |
| US63/315,581 | 2022-03-02 | ||
| US63/315,579 | 2022-03-02 | ||
| US202363442966P | 2023-02-02 | 2023-02-02 | |
| US63/442,966 | 2023-02-02 | ||
| PCT/US2023/063587 WO2023168341A1 (en) | 2022-03-02 | 2023-03-02 | Engineered cells and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507864A true JP2025507864A (ja) | 2025-03-21 |
| JP2025507864A5 JP2025507864A5 (cg-RX-API-DMAC10.html) | 2026-03-09 |
Family
ID=87884252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552028A Pending JP2025507864A (ja) | 2022-03-02 | 2023-03-02 | 操作された細胞および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4486870A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025507864A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119137262A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023227880A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3253740A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023168341A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117030580B (zh) * | 2023-09-15 | 2024-07-16 | 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) | LDNs在坏死性小肠结肠炎诊断中的应用 |
| WO2026123001A2 (en) * | 2024-12-06 | 2026-06-11 | Umoja Biopharma, Inc. | Lineage-loci engineered cell therapy and related methods of producing and using same |
| WO2026133125A1 (en) * | 2024-12-16 | 2026-06-25 | Janssen Biotech, Inc. | T cell-specific promoters and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0716570A4 (en) * | 1993-09-03 | 1997-12-17 | Systemix Inc | Genetically Modified Human Hematopoietic Stem Cells and Their Offspring |
| AU2018301667A1 (en) * | 2017-07-12 | 2020-02-06 | Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation | Methods and systems for conditionally regulating gene expression |
| EP4171616A1 (en) * | 2020-06-26 | 2023-05-03 | Juno Therapeutics GmbH | Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods |
-
2023
- 2023-03-02 JP JP2024552028A patent/JP2025507864A/ja active Pending
- 2023-03-02 WO PCT/US2023/063587 patent/WO2023168341A1/en not_active Ceased
- 2023-03-02 CN CN202380037757.5A patent/CN119137262A/zh active Pending
- 2023-03-02 EP EP23764131.1A patent/EP4486870A4/en active Pending
- 2023-03-02 CA CA3253740A patent/CA3253740A1/en active Pending
- 2023-03-02 AU AU2023227880A patent/AU2023227880A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023168341A1 (en) | 2023-09-07 |
| EP4486870A1 (en) | 2025-01-08 |
| CA3253740A1 (en) | 2023-09-07 |
| AU2023227880A1 (en) | 2024-10-17 |
| EP4486870A4 (en) | 2026-05-20 |
| CN119137262A (zh) | 2024-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023202195B2 (en) | Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells | |
| JP7580726B2 (ja) | 操作されたオフザシェルフ免疫細胞およびそれらの使用方法 | |
| AU2019287483B2 (en) | Stem cell-engineered iNKT cell-based off-the-shelf cellular therapy | |
| EP4486870A1 (en) | Engineered cells and methods of use | |
| WO2024102707A1 (en) | Methods and compositions for generating immune cells from progenitor cells | |
| WO2025208050A2 (en) | Engineered mucosal-associated invariant t (mait) cells and methods of making and using thereof | |
| EP4735581A2 (en) | Methods of making and using engineered immune cells | |
| WO2023224923A2 (en) | Engineered cells and methods of use | |
| JP2026506126A (ja) | 既製の細胞療法のための多能性幹細胞操作免疫細胞 | |
| WO2025054202A1 (en) | Method of screening a sample comprising a transgene with a unique barcode | |
| EA048607B1 (ru) | Способы получения т-клеток из стволовых клеток и иммунотерапевтические способы применения т-клеток |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260227 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260227 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260723 |